Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Aminobenzoic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Aminobenzoic-acid | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.51E-02 | 1 | P51649 | ALDH5A1 | More | | Aminobenzoic-acid | hsa00531 | Glycosaminoglycan degradation | 3.03E-02 | 1 | P15586 | GNS | More | | Aminobenzoic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Aminobenzoic-acid | hsa01524 | Platinum drug resistance | 2.55E-02 | 2 | P04637, P48023 | TP53, FASLG | More | | Aminobenzoic-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Aminobenzoic-acid | hsa04068 | FoxO signaling pathway | 6.45E-03 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | | Aminobenzoic-acid | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 6 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Aminobenzoic-acid | hsa04140 | Autophagy - animal | 3.72E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Aminobenzoic-acid | hsa04151 | PI3K-Akt signaling pathway | 4.21E-03 | 3 | P48023, P04637, Q96BR1 | FASLG, TP53, SGK3 | More | | Aminobenzoic-acid | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Aminobenzoic-acid | hsa04612 | Antigen processing and presentation | 3.74E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Aminobenzoic-acid | hsa04613 | Neutrophil extracellular trap formation | 4.94E-02 | 11 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, P49913, P21730, P21462 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Aminobenzoic-acid | hsa04621 | NOD-like receptor signaling pathway | 2.27E-02 | 9 | Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Aminobenzoic-acid | hsa04640 | Hematopoietic cell lineage | 3.58E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Aminobenzoic-acid | hsa04650 | Natural killer cell mediated cytotoxicity | 2.88E-03 | 10 | P01375, O60880, P20963, P48023, Q13241, P26718, O75015, P26717, Q14953, P26715 | TNF, SH2D1A, CD247, FASLG, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Aminobenzoic-acid | hsa04658 | Th1 and Th2 cell differentiation | 1.48E-02 | 7 | Q04759, P20963, P09693, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, STAT4, GATA3, TBX21, HLA-DOB | More | | Aminobenzoic-acid | hsa04660 | T cell receptor signaling pathway | 3.19E-03 | 10 | P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P20963, P09693, P01732, Q13191 | TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB | More | | Aminobenzoic-acid | hsa04672 | Intestinal immune network for IgA production | 1.66E-02 | 3 | P10747, P13765, P13612 | CD28, HLA-DOB, ITGA4 | More | | Aminobenzoic-acid | hsa04722 | Neurotrophin signaling pathway | 2.27E-02 | 2 | P48023, P04637 | FASLG, TP53 | More | | Aminobenzoic-acid | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Aminobenzoic-acid | hsa04927 | Cortisol synthesis and secretion | 1.66E-02 | 3 | Q14643, P18848, P22694 | ITPR1, ATF4, PRKACB | More | | Aminobenzoic-acid | hsa04940 | Type I diabetes mellitus | 3.64E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Aminobenzoic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Aminobenzoic-acid | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Aminobenzoic-acid | hsa04970 | Salivary secretion | 4.92E-02 | 4 | P07550, P22694, Q14643, P49913 | ADRB2, PRKACB, ITPR1, CAMP | More | | Aminobenzoic-acid | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Aminobenzoic-acid | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Aminobenzoic-acid | hsa05144 | Malaria | 5.57E-04 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Aminobenzoic-acid | hsa05146 | Amoebiasis | 1.48E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Aminobenzoic-acid | hsa05150 | Staphylococcus aureus infection | 1.02E-03 | 7 | P21730, P21462, O75015, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Aminobenzoic-acid | hsa05160 | Hepatitis C | 3.81E-02 | 2 | P04637, P48023 | TP53, FASLG | More | | Aminobenzoic-acid | hsa05164 | Influenza A | 3.48E-02 | 2 | Q9GZY0, P48023 | NXF2; NXF2B, FASLG | More | | Aminobenzoic-acid | hsa05168 | Herpes simplex virus 1 infection | 4.54E-03 | 4 | P04637, Q9GZY0, P48023, P98182 | TP53, NXF2; NXF2B, FASLG, ZNF200 | More | | Aminobenzoic-acid | hsa05202 | Transcriptional misregulation in cancer | 3.71E-02 | 11 | P14780, P27930, Q15744, Q16548, P35226, P05164, P12838, P08246, Q9C0K0, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, BMI1, MPO, DEFA4, ELA2, BCL11B, LYL1, GADD45A | More | | Aminobenzoic-acid | hsa05219 | Bladder cancer | 4.51E-02 | 1 | P04637 | TP53 | More | | Aminobenzoic-acid | hsa05310 | Asthma | 1.66E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Aminobenzoic-acid | hsa05321 | Inflammatory bowel disease | 1.14E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Aminobenzoic-acid | hsa05323 | Rheumatoid arthritis | 1.58E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Aminobenzoic-acid | hsa05332 | Graft-versus-host disease | 2.03E-03 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Aminobenzoic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | |